K.Ä.B

K.Ä.B. (K.Ä.B. Medizinische Produkte GmbH) is a specialized medical technology company based in Oberhaching, Germany, focused on the field of regional chemotherapy (RCT). Since its founding in 1991, the company has developed and manufactured high-precision delivery systems, including specialized port systems and catheters, designed for the targeted administration of oncological drugs. These devices allow clinicians to deliver high concentrations of cytotoxic agents directly to specific organs or body regions, such as the liver or limbs, thereby increasing local treatment efficacy while reducing systemic toxicity. K.Ä.B.'s product portfolio is essential for interventional oncology procedures and is used globally in specialized cancer centers. The company remains a private, independent entity dedicated to improving the quality of life for cancer patients through innovative delivery solutions.